BNET Industries
Schering-Plough Corp. (SGP) is in the Pharma Industry
- Revenue
- Dec 31 2007
- $12.6B
- Profit
- Dec 31 2007
- ($1.4B)
- Market Cap
- Nov 28 2008
- $27.3B
Latest News and Analysis
Schering-Plough strikes deal for rights to spray that fights cold virus.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
Merger of Merck, Schering-Plough would create third-largest pharmaceutical.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
Schering-Plough to Develop 88-Acre Summit, N.J., Site.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
Schering-Plough to Pay $27 Million to Settle Fraud Allegation.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
Schering-Plough Shareholders Applaud New CEO.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
Schering-Plough, Activist Group to Improve Drug Access.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
Schering-Plough CEO Discusses Pharmaceutical Industry.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
Schering-Plough CEO Sings Praises of Medicare Drug Plan.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
Schering-Plough to Lay Off 110 in New Jersey; Firm Freezes Global Hiring.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
Schering-Plough Corp. Posts Second Consecutive Quarterly Decline.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
'Wounded' Schering-Plough Details Its Recipe for Recovery.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
Merck, Schering-Plough Hope for Approval of Joint Cholesterol Treatment.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
FDA Approves Schering-Plough's Hepatitis C Treatment.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
Schering-Plough Probe Wraps Up; New Jersey Drug Maker Won't Face Penalties.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
Schering-Plough Boosts Its Hepatitis Treatment, Challenges Hoffman-LaRoche.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
Schering-Plough to Pay $1 Million to Settle SEC Disclosure Charges.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
Schering-Plough Delivers Heavy Dose of Bad News.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
Schering-Plough Plans Several Steps to Reduce Costs.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
Schering-Plough Says It Is Running Out of Cash.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
FDA Approves Schering-Plough Plan for Four Plants.
By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
- Next »
- page 1 of 3
- « Previous
Sort byClose
View Related Content by Tag Close
Key Competitors
Industry Transcripts by Seeking Alpha
-
Indevus Pharmaceuticals, Inc. F4Q08 (Qtr End 09/30/08) Earnings Call Transcript
on Nov 25, 2008about IDEV
-
Noven Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about NOVN
-
XenoPort, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about XNPT
-
Repligen Corporation F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
on Nov 24, 2008about RGEN
-
Omrix Biopharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about OMRI
Schering-Plough Corp. Company Info
Contact Information
2000 Galloping Hill Road
Kenilworth, NJ
http://www.schering-plough.com
908 298-4000
NAICS Code
Pharmaceutical Preparation Manufacturing: 325412
